Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
$4.76B |
| 2 |
Microsoft
MSFT
|
$1.4B |
| 3 |
NVIDIA
NVDA
|
$1.4B |
| 4 |
Amazon
AMZN
|
$1.22B |
| 5 |
Broadcom
AVGO
|
$1.21B |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$150M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$139M |
| 5 |
Cadence Design Systems
CDNS
|
$110M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 11.53% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Imunon
IMNN
$14.5M
| $134K | ﹤0.01% |
9,655
+3,932
| +69% | +$54.4K |
|
4027
Astrotech Corp
ASTC
$8.47M
| $133K | ﹤0.01% |
16,451
-4,100
| -20% | -$33.2K |
|
4028
Talphera
TLPH
$11.3M
| $133K | ﹤0.01% |
155,495
+12,363
| +9% | +$10.6K |
|
4029
SHF Holdings
SHFS
$13.1M
| $133K | ﹤0.01% |
12,028
+2,407
| +25% | +$26.6K |
|
|
ADAP
4030
Adaptimmune Therapeutics
ADAP
$10.9M
| $133K | ﹤0.01% |
139,801
+21,892
| +19% | +$20.8K |
|
4031
FlexShopper
FPAY
$18.3M
| $132K | ﹤0.01% |
128,074
-17,183
| -12% | -$17.7K |
|
4032
Cosmos Holdings
COSM
$19.6M
| $131K | ﹤0.01% |
149,728
+25,030
| +20% | +$21.9K |
|
4033
NRX Pharmaceuticals
NRXP
$65.4M
| $131K | ﹤0.01% |
77,341
+11,682
| +18% | +$19.7K |
|
|
XELA
4034
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $129K | ﹤0.01% |
62,823
+1,391
| +2% | +$2.87K |
|
|
SKGR
4035
DELISTED
SK Growth Opportunities Corporation Class A Common Stock
SKGR
| $129K | ﹤0.01% |
11,403
| – | – |
|
4036
Ceragon Networks
CRNT
$180M
| $127K | ﹤0.01% |
46,357
+5,384
| +13% | +$14.8K |
|
4037
Tevogen Bio Holdings
TVGN
$170M
| $127K | ﹤0.01% |
344,285
+3,483
| +1% | +$1.28K |
|
|
API
4038
Agora
API
$310M
| $127K | ﹤0.01% |
52,617
| – | – |
|
|
AIM
4039
AIM ImmunoTech Inc.
AIM
$6.72M
| $125K | ﹤0.01% |
4,640
+630
| +16% | +$17K |
|
|
SPRB
4040
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $124K | ﹤0.01% |
261,948
+57,946
| +28% | +$27.5K |
|
4041
urban-gro
UGRO
$6.31M
| $124K | ﹤0.01% |
90,124
+4,182
| +5% | +$5.77K |
|
4042
The Oncology Institute
TOI
$309M
| $124K | ﹤0.01% |
379,981
+19,717
| +5% | +$6.45K |
|
4043
Spring Valley Acquisition Corp II
SVII
$118M
| $123K | ﹤0.01% |
+10,991
| New | +$123K |
|
|
HCVI
4044
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
| $123K | ﹤0.01% |
10,704
| – | – |
|
|
GVP
4045
DELISTED
GSE Systems, Inc.
GVP
| $123K | ﹤0.01% |
30,101
+8,042
| +36% | +$32.7K |
|
4046
iBio
IBIO
$16.4M
| $122K | ﹤0.01% |
55,022
+5,825
| +12% | +$12.9K |
|
4047
Trio-Tech International
TRT
$23.2M
| $122K | ﹤0.01% |
21,928
-1,236
| -5% | -$6.85K |
|
|
ONYX
4048
DELISTED
Onyx Acquisition Co. I Class A Ordinary Shares
ONYX
| $121K | ﹤0.01% |
10,724
| – | – |
|
4049
Willamette Valley Vineyards
WVVI
$24.3M
| $121K | ﹤0.01% |
34,786
+934
| +3% | +$3.25K |
|
4050
Tandy Leather Factory
TLF
$24.8M
| $121K | ﹤0.01% |
28,863
+1,711
| +6% | +$7.17K |
|